Formulation: A solid
Formal Name: (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl-d2]-4-(4-fluorophenyl)-piperidine-2,2,6,6-d4, monohydrochloride
Purity: ≥99% deuterated forms (d1-d6)
Formula Markup: C19H14D6FNO3 • HCl
Formula Weight: 371,9
Shelf life (days): 1460
Notes: Paroxetine-d6 is intended for use as an internal standard for the quantification of paroxetine (Item No. 14998) by GC- or LC-MS. Paroxetine is a selective serotonin reuptake inhibitor (SSRI; Ki = 0.04 nM).{24255} It is selective for the serotonin transporter (SERT) over the dopamine and norepinephrine transporters (Kis = 400 and 90 nM, respectively) as well as the serotonin (5-HT) receptor subtypes 5-HT1A and 5-HT2A, the histamine H1 receptor, α1- and α2-adrenergic receptors (α2-ARs), and muscarinic acetylcholine receptors (mAChRs; Kis = 21,168, 6,320, 13,746, 995, 3,915, and 42 nM, respectively).{24255,32156} Paroxetine (5 mg/kg) decreases immobility time in the forced swim test in mice.{63222} Formulations containing paroxetine have been used in the treatment of depression, obsessive-compulsive disorder (OCD), panic disorder, social and generalized anxiety disorders, and post-traumatic stress disorder (PTSD).
English
Deutsch
